Clinical Trials Directory

Trials / Completed

CompletedNCT00932477

Safety and Tolerability of Artificial Tears in Dry Eye Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.

Conditions

Interventions

TypeNameDescription
DRUGFormulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear1 to 2 drops into each eye three times per day
DRUGFormulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear1 to 2 drops into each eye three times per day
DRUGGlycerin and Polysorbate 80 based artificial tear1 to 2 drops into each eye three times per day

Timeline

Start date
2009-08-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2009-07-03
Last updated
2015-08-26
Results posted
2011-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00932477. Inclusion in this directory is not an endorsement.

Safety and Tolerability of Artificial Tears in Dry Eye Subjects (NCT00932477) · Clinical Trials Directory